Each effervescent tablet of 1000 mg contains:
2263 mg of calcium lactate gluconate and 1750 mg of calcium carbonate (equivalent to 1000 mg or 25 mmol of calcium).
Excipients: 3323mg of citric acid anhydrous (fine granulate), 30mg of aspartame (E 951), 500 mg of sodium hydrogen carbonate, 30 mg of Orange flavour powder (containing sorbitol (E 420) and dextrose).
THERAPEUTIC INDICATIONS
– Prevention and treatment of calcium deficiency
– Calcium supplement as an adjunct to specific therapy in the prevention and treatment of osteoporosis
– Rickets and osteomalacia, in addition to vitamin D3 therapy
CONTRAINDICATIONS
– Hypersensitivity to the active substances or to any of the excipients of the effervescent tablet
– Diseases and/or conditions resulting in hypercalcaemia and/or hypercalciuria
– Nephrocalcinosis, nephrolithiasis
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
For patients with mild hypercalciuria (exceeding 300 mg/24 hours or 7.5 mmol/24 hours), or with a history of urinary calculi, monitoring of calcium excretion in the urine is required. If necessary, the calcium dose should be reduced or therapy should be discontinued. An increased fluid intake is recommended for patients prone to formation of calculi in the urinary tract.
In patients with impaired renal function, calcium salts should be taken under medical supervision with monitoring of calcium and phosphate serum levels.
Reviews
There are no reviews yet.